Business Development

   

 

  

                                                                                          

Immunotope is seeking commercial partnerships with  biotechnology and pharmaceutical companies that develop immunotherapeutic vaccines, monoclonal antibody therapeutics and diagnostic tests for cancer and infectious diseases.

 

                        

 

Antigens available for outlicensing

                            

We have a variety of novel antigens available for clinical evaluation and outlicensing:

            

        

  • Lung cancer antigens

  • Pancreatic cancer antigens

  • Platinum resistant ovarian cancer antigens

  • Antibody therapeutic targets

  • Cancer diagnostic targets

For infectious diseases, we are seeking partnerships for antigen discovery, validation and development of therapeutic vaccines for Hepatitis B, Hepatitis C, Dengue virus, West Nile virus, smallpox and influenza.

 

 

 

 

 

 

.....................................................................................................................................................................

Clinical and Preclinical Programs
| Science & TechnologyCareers
Business Development | Services | Management and Boards | News and Media | Contact Us | Home

© Copyright Immunotope. All Rights Reserved.